(Credit: © pavel1964 - stock.adobe.com
In a Nutshell
- Female runners who took 20 grams of collagen peptides daily for four weeks showed a rise in P1NP, a marker of bone building, while the placebo group showed no such change.
- The collagen group also saw a drop in IL-6, an inflammatory protein tied to bone breakdown, while the placebo group’s levels held steady or rose slightly.
- Levels of sRANKL, a molecule that can trigger bone breakdown, fell in the collagen group and rose in the placebo group, though the broader sRANKL/OPG balance did not shift significantly.
Female distance runners push their bodies to extremes. They log dozens of miles each week, absorb thousands of ground-impact forces per run, and often struggle to eat enough to keep up with the energy their training demands. That combination creates a quiet crisis inside their bones, where the constant cycle of microscopic damage and repair can fall dangerously out of balance. A small but carefully designed clinical trial now points to a possible ally: a daily collagen supplement that appeared to shift two key biological markers in directions the researchers read as favorable for bone, raising a signal tied to bone building while lowering one tied to inflammation.
Bone stress injuries, which range from shin splints to full stress fractures, are startlingly common in competitive runners. Research cited in the study estimates that 30 to 60 percent of competitive runners have experienced one at some point, and female athletes face roughly twice the risk that male athletes do. Up to 20 percent of female distance runners may sustain one of these injuries every year. Against that backdrop, a team of researchers from several universities ran a four-week, double-blind, placebo-controlled trial, published in the journal Frontiers in Nutrition, to test whether collagen peptide supplementation could shift the biological signals that govern bone health in this high-risk group.
Collagen peptides are small protein fragments derived from animal collagen, the structural protein that gives bones and connective tissues their strength and flexibility. Research suggests they may influence bone-related biological pathways, though the precise mechanisms are still being studied. Earlier work in older, postmenopausal women produced mixed results, and almost no rigorous short-term trials had looked at young, hard-training female athletes, leaving a gap in the sports nutrition evidence.
Who Was in the Study and How It Worked
Researchers recruited female runners between the ages of 18 and 35 who were running at least 35 miles per week and had naturally occurring menstrual cycles. After screening, 22 participants completed the study and were split into two equal groups. One group received 20 grams of collagen peptides per day, dissolved in water. The other received a powder that matched the collagen in color, appearance, smell, and taste but contained 20 grams of a carbohydrate-based placebo. Neither the participants nor the researchers collecting data knew who was taking which supplement.
Both groups took their supplements within one hour of waking each morning and logged their daily intake in a shared document. Blood was drawn at the start and end of the four-week period, always within the first week of each participant’s menstrual cycle, to limit the natural hormonal swings that can affect bone markers. Participants avoided exercise for 24 hours before each blood draw and fasted overnight before arriving at the lab. All 22 participants finished the study, and no adverse effects were reported.
Blood samples were checked for several markers. Two focused on bone activity: P1NP, which reflects how actively the body is building new bone, and CTX-1, which reflects how actively it is dissolving old bone. Researchers also measured signaling molecules that link the immune system to bone, including sRANKL, a protein that can tell the body to speed up bone breakdown, and OPG, which acts as a brake on that process. Finally, they measured interleukin-6, or IL-6, an inflammatory signal that can push bone-dissolving activity.
What the Collagen Supplement Study Found in Female Runners
On the formation side, participants taking collagen peptides showed a rise in the bone-building marker P1NP, up about 5.1 percent over four weeks, while the control group showed no such change. The overall pattern of change differed significantly between the two groups, though a follow-up comparison of the exact size of each group’s change did not reach statistical significance.
When looking at bone breakdown, the marker CTX-1 did not change significantly in either group. Researchers note this marker is highly sensitive to recent meals, activity, and time of day, which makes short-term changes hard to catch. A more interesting pattern showed up with sRANKL, the molecule that can spur bone breakdown: levels dropped in the collagen group while rising in the control group, a statistically significant split. Worth noting, though, is that the overall balance of the bone-breaking and bone-protecting molecules, a measure called the sRANKL/OPG ratio, did not shift significantly over this short study, so that single result calls for caution.
Most notable was the result for IL-6. Participants in the collagen group showed a significant drop in this inflammatory protein over the four weeks, while levels in the placebo group held steady or ticked upward. This gap between the groups held up even after researchers accounted for several variables, though the small sample means it reads as an early signal rather than a settled finding.
What Collagen Could Mean for Female Runners and Bone Health
These results carry weight mainly because they come from athletes who rarely appear in bone research. A young woman logging 40-plus miles a week lives in a specific mix of mechanical stress, shifting hormones, and the constant risk of not eating enough to fuel her training, all of which can push bone metabolism in a harmful direction. That physiological setting is different enough that findings from postmenopausal women or male-heavy studies may not carry over.
Collagen peptides are already sold widely as dietary supplements, and no adverse effects turned up in this trial. Even so, the authors frame their work as pilot data. With just 22 participants, a four-week window, and no direct imaging of bone structure, it is far too early to say that taking collagen will prevent stress fractures or build denser bones. What the study offers is a biologically plausible early signal worth chasing in longer, larger trials, not a reason to start recommending the supplement for injury prevention.
For the runners who break these bones at twice the rate of men, that distinction is the whole point. Collagen is easy to find, and no adverse effects were reported over these four weeks, which makes it a tempting thing to reach for. But an encouraging shift in a few blood markers over four weeks is a place for science to keep digging, not a prescription for stronger bones.
Disclaimer: This article summarizes findings from a single, small pilot study for general informational purposes and is not medical or nutritional advice. The trial measured short-term changes in blood markers in 22 female distance runners over four weeks; it did not measure bone density, bone structure, or injury rates, and its results may not apply to other groups. Collagen supplementation was not shown to prevent stress fractures or improve bone strength. Anyone considering a supplement should speak with a qualified healthcare provider or registered dietitian first.
Paper Notes
Limitations
Several limitations should be kept in mind. First and foremost, this was a pilot study with only 22 participants, so it lacked the statistical power to draw firm, generalizable conclusions. P1NP and CTX-1 are blood-based markers of bone activity, not direct measures of bone strength, density, or fracture risk, so the findings describe biological signals rather than structural outcomes. Four weeks was also too short a window to observe any change in bone mass or architecture. Inflammatory testing was limited to a small panel of molecules measured at just two time points, giving little insight into how those signals moved day to day or how they interacted with the rest of the immune system. Circulating hormone levels were not directly measured, so individual differences in estrogen within the early menstrual cycle phase could have influenced results. Reported running mileage was verified through participants’ personal fitness trackers, and the energy-expenditure estimates drawn from heart rate monitors rely on proprietary calculations that have not been independently validated for free-living exercise. The trial was not prospectively registered, though all outcomes were defined before data collection began. Finally, the researchers acknowledge that some participants, particularly teammates, may have shared information about their supplements, which could have weakened the blinding.
Funding and Disclosures
Financial support for this research was provided by the National Strength and Conditioning Association Foundation. The authors declared that the work was conducted without any commercial or financial relationships that could be seen as a potential conflict of interest. They also declared that generative artificial intelligence was not used in creating the manuscript.
Publication Details
Paper Title: Effects of collagen peptide supplementation on bone turnover, cytokine, and inflammatory markers in female distance runners: a randomized pilot study
Authors: Nicholas M. Kuhlman, Andrew R. Jagim, Christopher N. Blesso, Michael J. Puglisi, Ock K. Chun, Margaret T. Jones, and Jennifer B. Fields
Author Affiliations: Fitchburg State University; University of Connecticut; Mayo Clinic Health System; George Mason University
Journal: Frontiers in Nutrition
Publication Date: May 14, 2026
DOI: 10.3389/fnut.2026.1825906
Edited by: Matthew J. Barnes, Massey University, New Zealand
Reviewed by: Kevin Bischof, University of Vienna, Austria; Chris Nulty, South East Technological University, Ireland







